MoneyWorks4Me

Norris Medicines informs about disclosure of material impact of covid-19

01 Jun 2020 Evaluate

Pursuant to SEBI Circular SEBI/HO/CFD/CMD1/CIR/P/2020/84 dated May 20, 2020, Norris Medicines has informed that it has enclosed the disclosure on material impact of COVID-19 pandemic on the Company.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1736.85
Dr. Reddys Labs. 1240.15
Cipla 1317.90
Lupin 1940.00
Zydus Lifesciences 1113.95
View more..